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Background: Propofol is the most commonly using intravenous hypnotic for the induction and maintenance of 
general anesthesia. However, pain on propofol injection is a well known adverse event. Currently, acute and chronic 
pain can be controlled by utilizing the “gate control" theory.
Methods: Patients were randomized to receive lidocaine (0.5 mg/kg; Group L), touch on IV injection site (Group 
T), combination lidocaine (0.5 mg/kg) and touch on IV injection site (Group B), or normal saline (Group S) with 
venous occlusion for 1 minute, followed by administration of propofol (0.5 mg/kg) into the largest dorsal vein of the 
hand. Immediately after administering propofol, an investigator blinded to the group assignments asked the patient 
about pain at the injection site and assessed pain intensity using a 4-point verbal rating scale (0 = none, 1 = mild, 2 = 
moderate, 3 = severe). 
Results: A significant decrease in the incidence of pain on propofol injection was achieved in group L (37%) and 
group B (23%) compared to either group T (80%) and group S (83%) (P < 0.001). But, the incidence of moderate and 
severe pain was significantly lower in group L (7%), group T (20%) and group B (0%) when compared to group S (53%) 
(P < 0.05).
Conclusions: Light touch and rubbing reduced pain, although while, they did not reduce the incidence of pain, they 
reduced the intensity of pain. This method might be considered as an alternative to other treatments but may be 
contraindicated for use with other drugs. (Korean J Anesthesiol 2011; 61: 288-291)
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Introduction
Propofol is the most commonly using intravenous hypnotic 
for the induction and maintenance of general anesthesia. 
However, pain on injection of propofol is a well known adverse 
event [1]. Its incidence has been reported from 28% to 90% [2]. 
Macario et al. [1] concluded that propofol injection pain ranked 
number 7 among 33 low morbidity clinical outcomes. For the 
reduction of pain on injection of propofol, several studies have 
been performed using pharmacologic and nonpharmacologic 
methods [3]. But, none of these has achieved the complete 
elimination of pain. Pretreatment with lidocaine with a rubber 
tourniquet occluding the proximal part of the arm has been 
reported to be the most effective in minimizing propofol 
injection pain [4].
Currently, acute and chronic pain can be controlled by using 
the “gate control” theory [5]. “Gate control” theory of pain was 
introduced by Melzack and Wall in the 1965 [6]. This theory 
proposed that stimulation of A beta fibers which are stimulated 
by touch and vibration, modulate the dorsal horn “gate” and 
therefore the nociceptive input from the periphery could be 
reduced [7]. The present study was conducted to evaluate 
the efficacy of touching and rubbing of IV injection site on 
propofol injection. We also investigated whether a combination 
of touching and rubbing of the IV injection site with IV 
administration of lidocaine, preceded by venous occlusion was 
associated with additional analgesic efficacy compared with 
either treatment alone.
Materials and Methods
This prospective, randomized, single-blinded, placebo 
controlled study was conducted at our hospital. Verbal informed 
consent was obtained from all patients before enrollment. 120 
patients aged 16 to 73 years, who were scheduled to undergo 
elective otolaryngologic surgery with general anesthesia and 
were American Society of Anesthesiologists physical status of 
I-III, were enrolled. Patients who have experienced adverse 
responses to propofol or lidocaine were excluded from the study. 
Patients were not allowed to receive analgesics or sedative drugs 
24 hours prior to surgery. No patient received preanesthetic 
medication. No patient had hepatic, renal, cardiac problems, 
neurologic deficits and psychiatric disorders. On arrival to the 
operating room, a 20-gauge intravenous cannula was inserted 
into the largest dorsal vein of the patient’s nondominant hand 
and Ringer’s lactate solution was administered at a rate of 10 
ml/kg/h. Patients were randomly assigned to 4 groups (n = 30/
group) that received either: lidocaine (0.5 mg/kg, IV; Group L), 
saline (3 ml) with touching on the IV injection site (Group T), 
lidocaine (0.5 mg/kg, IV) with touching on the IV injection site 
(Group B) or saline (3 ml; Group S). If the volume of lidocaine 
to be administrated was < 3 ml in group L and B, normal saline 
was injected at a total volume of 3 ml. Solutions were prepared 
by an independent anesthesiologist and investigator that did 
not know the contents of the solutions. All patients underwent 
venous occlusion for 1 minute and the prepared drug (lidocaine 
or saline) was injected over 10 seconds. After the occlusion 
was stopped, propofol (0.5 mg/kg, at room temperature, 23
oC) 
was delivered through the intravenous cannula at the rate of 1 
ml/sec. In group T and B, the injection site was gently touched 
and rubbed on proximal part of the IV injection site 3 times per 
second with the palm of the hand during propofol injection. 
Immediately after administering propofol, an investigator 
who was blinded to group assignment asked the patient about 
pain at the injection site and assessed pain intensity using a 
4-point verbal rating scale (VRS), with 0 = no pain (negative 
response to questioning); 1 = mild pain (pain reported only 
in response to questioning without any behavioral signs); 2 = 
moderate (accompanied by a behavioral signs or sign reported 
spontaneously without questioning); and 3 = severe pain 
(strong vocal response or response accompanied by facial 
grimacing, arm withdrawal, or tears) [8]. The overall incidence 
of pain (mild, moderate, or severe) on injection of propofol was 
assessed in each group. Thereafter, anesthesia was induced 
with propofol (2 mg/kg). After the loss of consciousness, 
rocuronium bromide (0.6 mg/kg) was administered for muscle 
relaxation and to facilitate tracheal intubation. Two minutes 
after rocuronium bromide injection, the trachea was intubated 
and anesthesia was maintained with desflurane (4.0% to 8.0% 
inspired concentration) and nitrous oxide (50% in oxygen) with 
controlled ventilation. Patients were monitored for 24 hours 
postoperatively for adverse events (pain, edema, wheal, and 
inflammation) at the injection site. 
All statistical analyses were performed with statistical 
software (SPSS, version 12.0 for Windows; SPSS, Chicago, 
Illinois). Continuous variables were expressed as mean ± 
standard deviation or median and categorical variables as 
frequencies, or percentage. Demographic data were analyzed 
using ANOVA for continuous variables and the chi-squared 
test for categorical variables. The chi-square test was used to 
analyze the incidence of pain and severe pain between groups. 
The Fisher’s exact test was also applied when the distribution 
of data was not normal. The Kruskal-Wallis rank test was used 
to analyze the difference in the median pain score. Analysis 
of tendency by the linear and linear trend analysis with chi-
squared test was used to assess the differences in the mean pain 
intensity score. P value of less than 0.05 was deemed statistically 
significant.290 www.ekja.org
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Results
A total of 120 patients completed the study. Each group 
comprised 30 patients. No patient was excluded from the study. 
Demographic characteristics including age, sex, height, and 
weight are presented in Table 1. No significant differences were 
observed among the 4 groups. The overall incidence of pain on 
injection of propofol was 37% (11/30) in group L, 23% (7/30) in 
group B, 80% (24/30) in group T, and 83% (25/30) on group S. 
There were significant differences on the incidence of pain in 
group L and group B compared with group T or group S (P < 
0.001). There is no difference on the incidence of pain between 
groups T and S. But, there was a significant difference in the 
incidence of moderate and severe pain with 7% (2/30) in group 
L, 20% (6/30) in group T and 0% (0/30) in group B compared 
with 53% (16/30) in group S (P < 0.05). There is no significant 
differences between group L and group T by fisher’s exact test (P 
= 0.254). But, a difference existed between group B and group 
T by a Fisher’s exact test (P = 0.024). With respect to the median 
pain scores, they were less in groups L, T and B than in group S (P 
< 0.05) (Table 2). The pain intensity score showed a tendency to 
decrease in groups T, L and B compared with group S (P < 0.05; 
Table 2). 
Discussion
Our results showed that touch and rubbing was not effica-
cious on the incidence of pain on propofol injection. However, 
moderate and severe pain expressed by the pain intensity score 
was significantly decreased by either lidocaine pretreatment 
or touching and rubbing of the IV injection site at the time of 
propofol injection. 
The mechanism of pain on the injection of propofol is not 
fully understood. However, the triggering of the kinin cascade 
system is thought to be a possible cause [9]. Several methods 
have been studied for the prevention of propofol injection 
pain. Nonpharmacologic methods including injection into 
a large vein, slow injection of propofol, diluting the propofol 
solutions, and cooling or warming of propofol have been 
studied [9-11]. Pharmacologic methods have been investigated 
including pretreatment with IV injection of local anesthetics 
(lidocaine, procaine, prilocaine) [9,12-14], dexamethasone [15], 
metoclopramide [16], aspirin or NSAIDs [17-20] and opioids 
(Fentanyl, Alfentanyl, Remifentanyl) [21-25]. The most common 
method is to mix lidocaine with propofol [9]. The mechanism 
of action of lidocaine in reducing propofol injection pain is 
unclear, but it is thought as its local anesthetic effect on the vein 
and stabilization of the kinin cascade [9]. Lidocaine appears to 
have its maximum effect when administered as a pretreatment 
with a venous tourniquet occluding the proximal part of the 
arm [3], but, it is contraindicated in patients with allergy to 
lidocaine. 
In the present report, we showed touching and rubbing is an 
alternative method for decreasing pain on injection of propofol: 
this procedure seems to have no drawbacks. The effect could 
be explained by the “gate control” theory that was introduced 
by Melzack and Wall in 1965 [6]. They proposed that A delta 
and C nerve fibers stimulated by pain and A beta nerve fibers 
stimulated by touch, pressure and vibration carry information 
from the site of injury to two terminus including the substantia 
gelatinosa and the second order transmission neurons in the 
spinal dorsal horn. Signals from both A delta, C nerve and A 
beta nerve fibers excite the second order transmission neurons 
and when the output of the second order transmission cells 
exceeds a critical level, pain begins. The action of inhibitory 
interneurons located in substantia gelatinosa inhibits 
activation of the second order transmission cells. The second 
order transmission cells are the gate on pain, and inhibitory 
interneurons located in substantia gelatinosa can close the gate. 
When A delta, C nerve and A beta nerve fibers were activated by 
a noxious event, they excite the second order transmission cell 
and also act on inhibitory interneurons located in substantia 
gelatinosa. The inhibitory effect of substantia gelatinosa 
neuronal activity is increased by A beta and decreased by A 
Table 1. Demographic Data of the Patients in This Study
Group L
(n = 30)
Group T
(n = 30)
Group B
(n = 30)
Group S
(n = 30)
Age (yr)
Sex (M/F)
Height (cm)
Weight (kg)
 39.3 (17.3)
16/14
163.4 (5.4)
58.1 (11.1)
37.0 (14.1)
15/15
165.3 (6.8)
60.2 (10.7)
 41.1 (16.4)
16/14
166.2 (9.6)
64.9 (10.9)
 34.2 (15.7)
15/15
164.1 (8.0)
58.7 (12.3)
Values are shown as mean (SD) or number of patients. Group L: 
lidocaine, 0.5 mg/kg, Group T: touch on IV injection site, Group B: 
lidocaine, 0.5 mg/kg + touch on IV injection site, Group S: saline, 3 
ml.
Table 2. Incidence and Intensity of Propofol Injection Pain
Group L
(n = 30)
Group T
(n = 30)
Group B
(n = 30)
Group S
(n = 30)
Incidence of pain
Median pain score
Pain intensity score
    0 (None)
    1 (Mild)
    2 (Moderate)
    3 (Severe)
11 (36.7)*
0
†
‡
19 (63.3)
9 (30.0)
2 (6.7)
0 (0.0)
24 (80.0)
1
†
‡
6 (20.0)
18 (60.0)
4 (13.3)
2 (6.7)
7 (23.3)*
0
†
‡
23 (76.7)
7 (23.3)
0 (0.0)
0 (0.0)
25 (83.3)
2
5 (16.7)
9 (30.0)
10 (33.3)
6 (20.0)
Values are shown as the number of patients (%). Group L: lidocaine, 
0.5 mg/kg, Group T: touch on IV injection site, Group B: lidocaine, 
0.5 mg/kg + touch on IV injection site, Group S: saline, 3 ml. *P < 
0.05 versus Group S by chi-square test. 
†P < 0.05 versus Group S by 
Kruskal-Wallis rank test. 
‡P < 0.05 versus Group S by chi-square test, 
linear and linear trend analysis.291 www.ekja.org
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delta and C nerve activities. Therefore, the A delta and C nerve 
fibers impede the inhibitory interneurons located in substantia 
gelatinosa (tending to open the gate) while the A beta nerve 
fibers excite the inhibitory interneurons located in substantia 
gelatinosa (tending to close the gate) [7]. This theory has 
been provided as the theoretical base for the clinical effects of 
neuromodulatory techniques ranging from transcutaneous 
electrical nerve stimulation to spinal cord stimulation and 
acupuncture [6].
The findings of the present study must be considered within 
the context of its limitations. First, a newer formulation of 
propofol, which contains 10% fat emulsion consisting of long-
chain triglyceride and medium-chain triglyceride, is associated 
with less pain on injection: this is not used at our institution 
because of cost. Second, the sample size of the study was relati-
vely small despite a sufficient number of patients per the results 
of the power analysis. Future researchers should consider these 
limitations.
The results of this study may provide important information 
about a nonpharmacologic method that reduces pain on injection 
of propofol. Only light touch and rubbing can reduce pain. 
Although, light touch and rubbing can’t reduce incidence of pain, 
it can reduce pain intensity. This method might be considered 
as an alternative while it is difficult or contraindicated for use 
with other drugs.
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